Chemotherapy for solid tumors
Kidney cancer
Indications for the active ingredients of the drug Xospata
Relapsed or refractory acute myeloid leukemia (AML) with FLT3 mutations - as monotherapy.
Take at a dose of 120 mg 1 time per day.
Indications for the active substance SOTORASIB
As monotherapy for the treatment of adult patients with advanced non-small cell lung cancer (NSCLC) with KRAS G12C mutation who have progressed after at least one prior line of systemic therapy.
